↓ Skip to main content

Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in Sweden

Overview of attention for article published in PharmacoEconomics - Open, June 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
5 X users
facebook
1 Facebook page

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
35 Mendeley
Title
Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in Sweden
Published in
PharmacoEconomics - Open, June 2019
DOI 10.1007/s41669-019-0150-3
Pubmed ID
Authors

Korinna Karampampa, Hanna Gyllensten, Fei Yang, Chantelle Murley, Emilie Friberg, Jan Hillert, Kristina Alexanderson

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 35 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 14%
Student > Bachelor 3 9%
Student > Ph. D. Student 3 9%
Professor > Associate Professor 3 9%
Other 2 6%
Other 6 17%
Unknown 13 37%
Readers by discipline Count As %
Medicine and Dentistry 6 17%
Pharmacology, Toxicology and Pharmaceutical Science 3 9%
Neuroscience 3 9%
Sports and Recreations 2 6%
Business, Management and Accounting 1 3%
Other 4 11%
Unknown 16 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2019.
All research outputs
#15,528,671
of 25,931,626 outputs
Outputs from PharmacoEconomics - Open
#193
of 378 outputs
Outputs of similar age
#193,649
of 370,622 outputs
Outputs of similar age from PharmacoEconomics - Open
#17
of 37 outputs
Altmetric has tracked 25,931,626 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 378 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 370,622 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.